
TY  - JOUR
TI  - ASBMR 29th Annual Meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 22
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650221407
DO  - doi:10.1002/jbmr.5650221407
SP  - s252
EP  - s301
PY  - 2007
ER  - 

TY  - JOUR
TI  - Research Abstract Program of the 12th Annual ACVIM Forum
JO  - Journal of Veterinary Internal Medicine
VL  - 8
IS  - 2
SN  - 0891-6640
UR  - https://doi.org/10.1111/j.1939-1676.1994.tb03213.x
DO  - doi:10.1111/j.1939-1676.1994.tb03213.x
SP  - 137
EP  - 189
PY  - 1994
ER  - 

TY  - JOUR
AU  - CHASE, VICKI
AU  - NEILD, ROSE
AU  - SADLER, CRAIG W.
AU  - BATEY, ROBERT G.
TI  - The medical complications of alcohol use: understanding mechanisms to improve management
JO  - Drug and Alcohol Review
VL  - 24
IS  - 3
SN  - 0959-5236
UR  - https://doi.org/10.1080/09595230500167510
DO  - doi:10.1080/09595230500167510
SP  - 253
EP  - 265
KW  - alcohol
KW  - alcohol-related tissue injury
KW  - cytokines
KW  - drug metabolism
KW  - genetic susceptibility
KW  - organ damage
KW  - oxidative stress
PY  - 2005
AB  - Abstract The use of alcohol in a dependent or even a regular heavy pattern predisposes the drinker to a range of adverse consequences. These include a risk of direct harm from alcohol, including organ damage, mental health disorders and a range of social and legal problems associated with behaviours due to alcohol's effects. The range of organ damage associated with regular heavy alcohol consumption is well described. Much new information on the mechanisms by which damage occurs is available and is reviewed in this paper. New knowledge can assist in the development of more appropriate management strategies for those affected by the medical complications of alcohol use. Genetic susceptibility to tissue injury is explored and the reasons why many heavy drinkers do not appear to experience organ damage are considered. Approaches to the management of certain alcohol-related disorders are outlined.
ER  - 

TY  - JOUR
TI  - Poster Session PTW08: Remyelination and differentiation
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_15.x
DO  - doi:10.1111/j.1474-1644.2005.03230_15.x
SP  - 109
EP  - 112
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session PTW01: Receptors, transmitters, and channels
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_8.x
DO  - doi:10.1111/j.1474-1644.2005.03230_8.x
SP  - 81
EP  - 84
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster session PTW06: Parkinson's and other diseases
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_13.x
DO  - doi:10.1111/j.1474-1644.2005.03230_13.x
SP  - 99
EP  - 103
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session PTW07: Demyelination
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_14.x
DO  - doi:10.1111/j.1474-1644.2005.03230_14.x
SP  - 104
EP  - 108
PY  - 2005
ER  - 

TY  - JOUR
AU  - Haydon, P.
TI  - Symposium S06: Astrocytic regulation of neuronal excitability and synaptic transmission
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_3.x
DO  - doi:10.1111/j.1474-1644.2005.03230_3.x
SP  - 72
EP  - 72
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Abstracts – 16 September
JO  - Journal of Gastroenterology and Hepatology
VL  - 23
IS  - s5
SN  - 0815-9319
UR  - https://doi.org/10.1111/j.1440-1746.2008.05627.x
DO  - doi:10.1111/j.1440-1746.2008.05627.x
SP  - A116
EP  - A163
PY  - 2008
ER  - 

TY  - JOUR
TI  - ASBMR 31st Annual Meeting 1001–1300
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 24
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650241301
DO  - doi:10.1002/jbmr.5650241301
SP  - S1
EP  - S93
PY  - 2009
ER  - 

TY  - JOUR
AU  - Nave, Klaus
TI  - Plenary Talk P03: Axon–glia interactions and the control of myelination
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_1.x
DO  - doi:10.1111/j.1474-1644.2005.03230_1.x
SP  - 69
EP  - 69
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session PTW03: Glia and inflammation II
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_10.x
DO  - doi:10.1111/j.1474-1644.2005.03230_10.x
SP  - 88
EP  - 91
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session PTW05: Ischemia
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_12.x
DO  - doi:10.1111/j.1474-1644.2005.03230_12.x
SP  - 95
EP  - 98
PY  - 2005
ER  - 

TY  - JOUR
AU  - Chandross, K.
AU  - Merrill, J.
TI  - Colloquium C11: Lipid pathways as targets for MS therapy
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_7.x
DO  - doi:10.1111/j.1474-1644.2005.03230_7.x
SP  - 79
EP  - 80
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session PTW02: Gene expression and signaling II
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_9.x
DO  - doi:10.1111/j.1474-1644.2005.03230_9.x
SP  - 85
EP  - 87
PY  - 2005
ER  - 

TY  - JOUR
TI  - Proceedings of the Combined Scientific Meeting of the New Zealand Rheumatology Association and the Australian Rheumatology Association with the New Zealand Health Professionals in Rheumatology and the Rheumatology Health Professionals Association of Australia - 2002
JO  - Internal Medicine Journal
VL  - 33
IS  - 3
SN  - 1444-0903
UR  - https://doi.org/10.1046/j.1445-5994.2003.00001.x
DO  - doi:10.1046/j.1445-5994.2003.00001.x
SP  - A1
EP  - A22
PY  - 2003
ER  - 

TY  - JOUR
TI  - Workshops
JO  - European Journal of Clinical Investigation
JA  - Eur J Clin Invest
VL  - 44
IS  - s1
SN  - 0014-2972
UR  - https://doi.org/10.1111/eci.12258
DO  - doi:10.1111/eci.12258
SP  - 4
EP  - 82
PY  - 2014
ER  - 

TY  - JOUR
TI  - SMALL ANIMAL LITERATURE INDEX
JO  - Journal of Small Animal Practice
VL  - 25
IS  - 4
SN  - 0022-4510
UR  - https://doi.org/10.1111/j.1748-5827.1984.tb00472.x
DO  - doi:10.1111/j.1748-5827.1984.tb00472.x
SP  - 223
EP  - 230
PY  - 1984
AB  - Photocopies of the articles cited below may be obtained from the Librarian. RCVS Wellcome Library. 32 Belgrave Square, London SW1X 8QP. Telephone 01?235 6568.
ER  - 

TY  - JOUR
AU  - Dunn, Andrew
AU  - Talovic, Muhamed
AU  - Patel, Krishna
AU  - Patel, Anjali
AU  - Marcinczyk, Madison
AU  - Garg, Koyal
TI  - Biomaterial and stem cell-based strategies for skeletal muscle regeneration
JO  - Journal of Orthopaedic Research
JA  - J. Orthop. Res.
VL  - 37
IS  - 6
SN  - 0736-0266
UR  - https://doi.org/10.1002/jor.24212
DO  - doi:10.1002/jor.24212
SP  - 1246
EP  - 1262
KW  - Skeletal muscle
KW  - stem cells
KW  - biomaterials
KW  - regeneration
PY  - 2019
AB  - ABSTRACT Adult skeletal muscle can regenerate effectively after mild physical or chemical insult. Muscle trauma or disease can overwhelm this innate capacity for regeneration and result in heightened inflammation and fibrotic tissue deposition resulting in loss of structure and function. Recent studies have focused on biomaterial and stem cell-based therapies to promote skeletal muscle regeneration following injury and disease. Many stem cell populations besides satellite cells are implicated in muscle regeneration. These stem cells include but are not limited to mesenchymal stem cells, adipose-derived stem cells, hematopoietic stem cells, pericytes, fibroadipogenic progenitors, side population cells, and CD133+ stem cells. However, several challenges associated with their isolation, availability, delivery, survival, engraftment, and differentiation have been reported in recent studies. While acellular scaffolds offer a relatively safe and potentially off-the-shelf solution to cell-based therapies, they are often unable to stimulate host cell migration and activity to a level that would result in clinically meaningful regeneration of traumatized muscle. Combining stem cells and biomaterials may offer a viable therapeutic strategy that may overcome the limitations associated with these therapies when they are used in isolation. In this article, we review the stem cell populations that can stimulate muscle regeneration in vitro and in vivo. We also discuss the regenerative potential of combination therapies that utilize both stem cell and biomaterials for the treatment of skeletal muscle injury and disease. ? 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 37:1246?1262, 2019.
ER  - 

AU  - Lombardi, Giovanni
AU  - Lippi, Giuseppe
AU  - Banfi, Giuseppe
C7  - pp. 229-241
TI  - Iron Requirements and Iron Status of Athletes
SN  - 9781118275764
UR  - https://doi.org/10.1002/9781118692318.ch19
DO  - doi:10.1002/9781118692318.ch19
SP  - 229-241
KW  - athletes
KW  - body iron recycling
KW  - intestinal absorption
KW  - iron deficiency
KW  - iron supplementation
PY  - 2019
AB  - Summary This chapter proposes a number of exercise-generated mechanisms to influence the iron status of an athlete including hemolysis, hematuria, sweating, gastrointestinal bleeding, and injuries. The need to supplement athletes with iron was first suggested by the evidence of changes in blood cell counts and iron-associated parameters during periods of intense training or, even more accentuated, at the start of the training. This condition is known as ?sports anemia? and is common in endurance athletes. The hematological changes that occur during intense training are paralleled by the fall in ferritin concentration, mirroring a depletion of the body iron stores, even though ferritin levels also depend upon a number of other factors such as liver disease, alcohol consumption, infections, cardiovascular disease, and aging. Other parameters that can be used to monitor the iron status include sTfR, red blood cells (RBC) protoporphyrin, and stainable bone marrow iron (hemosiderin).
ER  - 
